GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 792 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,165,000 | +2.8% | 26,756 | +2.8% | 0.13% | +16.8% |
| Q1 2022 | $1,133,000 | -7.1% | 26,017 | -5.9% | 0.11% | -5.8% |
| Q4 2021 | $1,219,000 | +0.8% | 27,648 | -12.7% | 0.12% | -10.4% |
| Q3 2021 | $1,209,000 | -11.0% | 31,653 | -7.3% | 0.13% | -13.5% |
| Q2 2021 | $1,359,000 | +9.2% | 34,137 | -2.1% | 0.16% | -3.1% |
| Q1 2021 | $1,245,000 | – | 34,877 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 5,993,336 | $264,217,000 | 32.64% |
| Black Creek Investment Management Inc. | 10,373,943 | $457,491,000 | 12.20% |
| KAHN BROTHERS GROUP INC | 1,438,569 | $63,440,893,000 | 8.71% |
| EQUITY INVESTMENT CORP | 2,932,078 | $129,305,000 | 4.68% |
| JET CAPITAL INVESTORS L P | 400,000 | $17,640,000 | 4.67% |
| Eversept Partners, LP | 1,503,700 | $66,313,170 | 4.24% |
| NKCFO LLC | 269,500 | $11,885,000 | 3.82% |
| Camber Capital Management LP | 2,500,000 | $110,250,000 | 3.79% |
| CLIFFORD CAPITAL PARTNERS LLC | 113,866 | $5,021,000 | 3.75% |
| Robinson Value Management, Ltd. | 97,677 | $4,308,000 | 3.54% |